Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor

Infection and Immunity

Volumn 82, Issue 10, 2014, Pages 4253-4264

  Ibberson, Carolyn B ^a   Jones, Crystal L ^b   Singh, Shweta ^b   Wise, Matthew C ^b   Hart, Mark E ^c   Zurawski, Daniel V ^b   Horswill, Alexander R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; HYALURONIC ACID; HYALURONIDASE; VIRULENCE FACTOR; BACTERIAL PROTEIN; CODY PROTEIN, STAPHYLOCOCCUS AUREUS; HYALURONATE LYASE; POLYSACCHARIDE LYASE; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CODY GENE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENE REPRESSION; LUNG; LUNG INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR LIBRARY; MOUSE; MOUSE MODEL; NEUTROPENIA; NONHUMAN; OPERON; PATHOGENESIS; REDUCTION; SARA GENE; SIGB GENE; STAPHYLOCOCCUS AUREUS; TISSUE LEVEL; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CYTOCHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; STAPHYLOCOCCAL PNEUMONIA; VIRULENCE;

ANIMALS; BACTERIAL LOAD; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HISTOCYTOCHEMISTRY; LUNG; MICE; MICE, INBRED BALB C; PNEUMONIA, STAPHYLOCOCCAL; POLYSACCHARIDE-LYASES; REPRESSOR PROTEINS; STAPHYLOCOCCUS AUREUS; VIRULENCE; VIRULENCE FACTORS;

EID: 84907092911     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01710-14     Document Type: Article

References (64)

1. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M. 2007. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin. Infect. Dis. 45:1132- 1140. http://dx.doi.org/10.1086/522186.
2. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532. http://dx.doi.org/10.1056/NEJM199808203390806.
3. Gordon RJ, Lowy FD. 2008. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46(Suppl. 5):S350-S359. http: //dx.doi.org/10.1086/533591.
4. David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23:616-687. http://dx.doi.org /10.1128/CMR.00081-09.
5. DeLeo FR, Chambers HF. 2009. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J. Clin. Invest. 119:2464-2474. http://dx.doi.org/10.1172/JCI38226.
6. Chambers HF, Deleo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7:629-641. http://dx.doi.org/10.1038/nrmicro2200.
7. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M. 2009. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 106:5883-5888. http://dx.doi.org/10.1073/pnas.0900743106.
8. Hart ME, Hart MJ, Roop AJ. 2009. Genotypic and phenotypic assessment of hyaluronidase among type strains of a select group of Staphylococcal species. Int. J. Microbiol. 2009:614371. http://dx.doi.org/10.1155 /2009/614371.
9. Hynes WL, Walton SL. 2000. Hyaluronidases of Gram-positive bacteria. FEMS Microbiol. Lett. 183:201-207. http://dx.doi.org/10.1111/j.1574-6968.2000.tb08958.x.
10. Laurent TC, Fraser, JR. 1992. Hyaluronan. FASEB J. 6:2397-2404.
11. Jiang DL, Liang J, Noble PW. 2011. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 91:221-264. http://dx.doi.org/10.1152 /physrev.00052.2009.
12. Smith LD. 1979. Virulence factors of Clostridium perfringens. Rev. Infect. Dis. 1:254-262. http://dx.doi.org/10.1093/clinids/1.2.254.
13. Starr CR, Engleberg NC. 2006. Role of hyaluronidase in subcutaneous spread and growth of group A Streptococcus. Infect. Immun. 74:40-48. http://dx.doi.org/10.1128/IAI.74.1.40-48.2006.
14. Li S, Jedrzejas MJ. 2001. Hyaluronan binding and degradation by Streptococcus agalactiae hyaluronate lyase. J. Biol. Chem. 276:41407-41416. http://dx.doi.org/10.1074/jbc.M106634200.
15. Li S, Kelly SJ, Lamani E, Ferraroni M, Jedrzejas MJ. 2000. Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. EMBO J. 19:1228-1240. http://dx.doi.org/10.1093/emboj/19.6.1228.
16. Zheng M, Zhang H, Xu D. 2012. Initial events in the degradation of hyaluronan catalyzed by hyaluronate lyase from Streptococcus pneumoniae: QM/MM simulation. J. Phys. Chem. B 116:11166-11172. http: //dx.doi.org/10.1021/jp306754a.
17. Duran-Reynals F. 1933. Studies on a certain spreading factor existing in bacteria and its significance for bacterial invasiveness. J. Exp. Med. 58: 161-181.
18. Chain E, Duthie ES. 1940. Identity of hyaluronidase and spreading factor. Br. J. Exp. Pathol. 21:324-338.
19. Favilli G. 1940. Mucolytic effect of natural and artificial spreading factors: mucolytic effect of several diffusing agents and of a dlazotized compound. Nature 145:866-867. http://dx.doi.org/10.1038/145866a0.
20. McClean D, Hale CW. 1940. Mucolytic effect of natural and artificial spreading factors: mucinase and tissue permeability. Nature 145:867-868. http://dx.doi.org/10.1038/145867a0.
21. Duran-Reynals F. 1942. Tissue permeability and the spreading factors in infection: a contribution to the host:parasite problem. Bacteriol. Rev. 6:197-252.
22. Hobby GL, Dawson MH, Meyer K, Chaffee E. 1941. The relationship between spreading factor and hyaluronidase. J. Exp. Med. 73:109-123. http://dx.doi.org/10.1084/jem.73.1.109.
23. Rogers H. 1953. Variant populations within a hyaluronidase-producing culture of Staphylococcus aureus. J. Pathol. Bacteriol. 66:545-551. http://dx.doi.org/10.1002/path.1700660226.
24. Rogers H. 1954. The rate of formation of hyaluronidase, coagulase and total extracellular protein by strains of Staphylococcus aureus. J. Gen. Microbiol. 10:209-220. http://dx.doi.org/10.1099/00221287-10-2-209.
25. Rogers H. 1957. The preferential suppression of hyaluronidase formation in cultures of Staphylococcus aureus. J. Gen. Microbiol. 16:22-37. http://dx.doi.org/10.1099/00221287-16-1-22.
26. Farrell AM, Taylor D, Holland KT. 1995. Cloning, nucleotide sequence determination and expression of the Staphylococcus aureus hyaluronate lyase gene. FEMS Microbiol. Lett. 130:81-85. http://dx.doi.org/10.1111/j.1574-6968.1995.tb07702.x.
27. Jones RC, Deck J, Edmondson RD, Hart ME. 2008. Relative quantitative comparisons of the extracellular protein profiles of Staphylococcus aureus UAMS-1 and its sarA, agr, and sarA agr regulatory mutants using onedimensional polyacrylamide gel electrophoresis and nanocapillary liquid chromatography coupled with tandem mass spectrometry. J. Bacteriol. 190:5265-5278. http://dx.doi.org/10.1128/JB.00383-08.
28. Makris G, Wright JD, Ingham E, Holland KT. 2004. The hyaluronate lyase of Staphylococcus aureus-a virulence factor? Microbiology 150: 2005-2013. http://dx.doi.org/10.1099/mic.0.26942-0.
29. Hart ME, Tsang LH, Deck J, Daily ST, Jones RC, Liu H, Hu H, Hart MJ, Smeltzer MS. 2013. Hyaluronidase expression and biofilm involvement in Staphylococcus aureus UAMS-1 and its sarA, agr and sarA agr regulatory mutants. Microbiology 159:782-791. http://dx.doi.org/10.1099/mic.0.065367-0.
30. Schenk S, Laddaga RA. 1992. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 94:133-138. http://dx.doi.org/10.1111/j.1574-6968.1992.tb05302.x.
31. Wormann ME, Reichmann NT, Malone CL, Horswill AR, Grundling A. 2011. Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase. J. Bacteriol. 193:5279-5291. http://dx.doi.org/10.1128/JB.00369-11.
32. Bose JL, Fey PD, Bayles KW. 2013. Genetic tools to enhance the study of gene function and regulation in Staphylococcus aureus. Appl. Environ. Microbiol. 79:2218-2224. http://dx.doi.org/10.1128/AEM.00136-13.
33. Pohl K, Francois P, Stenz L, Schlink F, Geiger T, Herbert S, Goerke C, Schrenzel J, Wolz C. 2009. CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J. Bacteriol. 191: 2953-2963. http://dx.doi.org/10.1128/JB.01492-08.
34. Thompson MG, Black CC, Pavlicek RL, Honnold CL, Wise MC, Alamneh YA, Moon JK, Kessler JL, Si Y, Williams R, Yildirim S, Kirkup BC, Jr, Green RK, Hall ER, Palys TJ, Zurawski DV. 2014. Validation of a novel murine wound model of Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 58:1332-1342. http://dx.doi.org/10.1128/AAC.01944-13.
35. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
36. El-Chemaly S, Malide D, Zudaire E, Ikeda Y, Weinberg BA, Pacheco-Rodriguez G, Rosas IO, Aparicio M, Ren P, MacDonald SD, Wu HP, Nathan SD, Cuttitta F, McCoy JP, Gochuico BR, Moss J. 2009. Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc. Natl. Acad. Sci. U. S. A. 106:3958-3963. http://dx.doi.org/10.1073/pnas.0813368106.
37. Monzon ME, Casalino-Matsuda SM, Forteza RM. 2006. Identification of glycosaminoglycans in human airway secretions. Am. J. Respir. Cell Mol. Biol. 34:135-141. http://dx.doi.org/10.1165/rcmb.2005-0256OC.
38. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739. http://dx.doi.org/10.1016/S0140-6736(06)68231-7.
39. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. http://dx.doi.org/10.1371/journal.pone.0010146.
40. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 4(1):e00537-12. http://dx.doi.org/10.1128/mBio.00537-12.
41. Majerczyk CD, Dunman PM, Luong TT, Lee CY, Sadykov MR, Somerville GA, Bodi K, Sonenshein AL. 2010. Direct targets of CodY in Staphylococcus aureus. J. Bacteriol. 192:2861-2877. http://dx.doi.org/10.1128 /JB.00220-10.
42. Majerczyk CD, Sadykov MR, Luong TT, Lee C, Somerville GA, Sonenshein AL. 2008. Staphylococcus aureus CodY negatively regulates virulence gene expression. J. Bacteriol. 190:2257-2265. http://dx.doi.org/10.1128 /JB.01545-07.
43. Rivera FE, Miller HK, Kolar SL, Stevens SM, Shaw LN. 2012. The impact of CodY on virulence determinant production in community-associated methicillin-resistant Staphylococcus aureus. Proteomics 12:263-268. http://dx.doi.org/10.1002/pmic.201100298.
44. Belitsky BR, Sonenshein AL. 2008. Genetic and biochemical analysis of CodY-binding sites in Bacillus subtilis. J. Bacteriol. 190:1224-1236. http://dx.doi.org/10.1128/JB.01780-07.
45. Brinsmade SR, Kleijn RJ, Sauer U, Sonenshein AL. 2010. Regulation of CodY activity through modulation of intracellular branched-chain amino acid pools. J. Bacteriol. 192:6357-6368. http://dx.doi.org/10.1128/JB.00937-10.
46. Stenz L, Francois P, Whiteson K, Wolz C, Linder P, Schrenzel J. 2011. The CodY pleiotropic repressor controls virulence in gram-positive pathogens. FEMS Immunol. Med. Microbiol. 62:123-139. http://dx.doi.org/10.1111/j.1574-695X.2011.00812.x.
47. Montgomery CP, Boyle-Vavra S, Roux A, Ebine K, Sonenshein AL, Daum RS. 2012. CodY deletion enhances in vivo virulence of communityassociated methicillin-resistant Staphylococcus aureus clone USA300. Infect. Immun. 80:2382-2389. http://dx.doi.org/10.1128/IAI.06172-11.
48. Lauderdale KJ, Boles BR, Cheung AL, Horswill AR. 2009. Interconnections between sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect. Immun. 77:1623-1635. http://dx.doi.org /10.1128/IAI.01036-08.
49. Fraser JR, Laurent TC, Laurent UB. 1997. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242:27-33. http://dx.doi.org/10.1046/j.1365-2796.1997.00170.x.
50. Skaar EP. 2010. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 6:e1000949. http://dx.doi.org/10.1371 /journal.ppat.1000949.
51. Jones CL, Napier BA, Sampson TR, Llewellyn AC, Schroeder MR, Weiss DS. 2012. Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76:383-404. http://dx.doi.org /10.1128/MMBR.05027-11.
52. Somerville GA, Proctor RA. 2009. At the crossroads of bacterial metabolism and virulence factor synthesis in staphylococci. Microbiol. Mol. Biol. Rev. 73:233-248. http://dx.doi.org/10.1128/MMBR.00005-09.
53. Costagliola C, Del Prete A, Winkler NR, Carpineto P, Ciancaglini M, Piccolomini R, Mastropasqua L. 1996. The ability of bacteria to use Na-hyaluronate as a nutrient. Acta Ophthalmol. Scand. 74:566-568.
54. Marion C, Stewart JM, Tazi MF, Burnaugh AM, Linke CM, Woodiga SA, King SJ. 2012. Streptococcus pneumoniae can utilize multiple sources of hyaluronic acid for growth. Infect. Immun. 80:1390-1398. http://dx.doi.org/10.1128/IAI.05756-11.
55. Hirayama Y, Yoshimura M, Ozeki Y, Sugawara I, Udagawa T, Mizuno S, Itano N, Kimata K, Tamaru A, Ogura H, Kobayashi K, Matsumoto S. 2009. Mycobacteria exploit host hyaluronan for efficient extracellular replication. PLoS Pathog. 5:e1000643. http://dx.doi.org/10.1371/journal.ppat.1000643.
56. Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, Potempa J. 2005. Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J. Exp. Med. 201:1669-1676. http://dx.doi.org/10.1084/jem.20042041.
57. Stehr F, Kretschmar M, Kro¨ger C, Hube B, Scha¨fer W. 2003. Microbial lipases as virulence factors. J. Mol. Catalysis B Enzym. 22:347-355. http://dx.doi.org/10.1016/S1381-1177(03)00049-3.
58. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
59. Nair D, Memmi G, Hernandez D, Bard J, Beaume M, Gill S, Francois P, Cheung AL. 2011. Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J. Bacteriol. 193:2332-2335. http://dx.doi.org/10.1128/JB.00027-11.
60. Benson MA, Lilo S, Wasserman GA, Thoendel M, Smith A, Horswill AR, Fraser J, Novick RP, Shopsin B, Torres VJ. 2011. Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol. Microbiol. 81:659-675. http://dx.doi.org/10.1111/j.1365-2958.2011.07720.x.
61. Mootz JM, Malone CL, Shaw LN, Horswill AR. 2013. Staphopains modulate Staphylococcus aureus biofilm integrity. Infect. Immun. 81: 3227-3238. http://dx.doi.org/10.1128/IAI.00377-13.
62. Kiedrowski MR, Kavanaugh JS, Malone CL, Mootz JM, Voyich JM, Smeltzer MS, Bayles KW, Horswill AR. 2011. Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLoS One 6:e26714. http://dx.doi.org/10.1371/journal.pone.0026714.
63. Olson ME, King JM, Yahr TL, Horswill AR. 2013. Sialic acid catabolism in Staphylococcus aureus. J. Bacteriol. 195:1779-1788. http://dx.doi.org/10.1128/JB.02294-12.
64. Bateman BT, Donegan NP, Jarry TM, Palma M, Cheung AL. 2001. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect. Immun. 69:7851-7857. http://dx.doi.org /10.1128/IAI.69.12.7851-7857.2001.